Biotechnology

Hancock Jaffe Submits IDE Application to FDA for VenoValve U.S. Pivotal Trial

March 8, 2021 8:30 AM

IRVINE, CA / ACCESSWIRE / March 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) seeking approval to begin a U.S. pivotal trial for the VenoValve®. The VenoValve is an implantable valve designed to restore proper directional...

Read more

Apollo Endosurgery announces AMA assignment of Category I CPT Codes for use in Intragastric Balloon Procedures

March 8, 2021 8:30 AM

AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the assignment of Category I Current Procedural Terminology (CPT®) codes with short form descriptor esophagogastroduodenoscopy with deployment of gastric bariatric device (e.g., balloon) under endoscopic guidance. The codes and descriptor will...

Read more

Community and Business Joining Together to Safely Reopen America

March 8, 2021 8:00 AM

WASHINGTON, DC / ACCESSWIRE / March 8, 2021 / Business leaders and community organizations have joined forces to support R.E.S.T., "Reopening Effectively and Safely Together", a multi-state mission and initiative created and designed to address the tough challenges ahead as we look forward to the post-COVID-19 world. Assembly of Petworth Healthcare Coalition, MAD Konnect LLC, and Oxi-Thyme North America, Inc., have cooperatively recognized...

Read more

Xenetic Biosciences, Inc. to Present at the H.C. Wainwright Global Life Sciences Conference

March 3, 2021 8:05 AM

FRAMINGHAM, MA / ACCESSWIRE / March 3, 2021 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today that Jeffrey Eisenberg, Chief Executive Officer of Xenetic will present at the virtual H.C. Wainwright Global Life Sciences Conference taking place March...

Read more

Apollo Endosurgery to Present at HC Wainwright Global Life Sciences Conference

March 3, 2021 8:00 AM

AUSTIN, TX / ACCESSWIRE / March 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will participate in the H.C. Wainwright Global Life Sciences Conference taking place virtually March 9-10, 2021. Management will provide a pre-recorded presentation which will be available to registered investors on demand via the...

Read more

Tetra Bio-Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference

March 3, 2021 7:00 AM

OTTAWA, ON / ACCESSWIRE / March 3, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announces that CEO Dr. Guy Chamberland will present a company overview and hold virtual investor meetings at the H.C. Wainwright Global Life Sciences Virtual Conference being held March 9-10, 2021. The Tetra Bio-Pharma webcast presentation can be...

Read more

Edesa Biotech Announces Closing of $10 Million Bought Deal Offering of Common Shares

March 2, 2021 4:10 PM

TORONTO, ON / ACCESSWIRE / March 2, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced the closing of its previously announced underwritten public offering of 1,562,500 common shares of Edesa, at a price to the public of $6.40 per share, less underwriting discounts and commissions. The gross proceeds were $10.0 million, before deducting...

Read more

MorphoSys's Licensing Partner GSK Shared Preliminary Results From OSCAR Study with Otilimab for the Treatment of Severe Pulmonary COVID-19 Related Disease; Expanding the Study for Patients 70 Years and Older

March 2, 2021 4:01 PM

PLANEGG/MUNICH, GERMANY / ACCESSWIRE / March 2, 2021 / MorphoSys AG (FSE:MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ:MOR), a commercial-stage biopharmaceutical company and a leader in antibody, protein and peptide technologies, announced today that its licensing partner GlaxoSmithKline plc (LSE/NYSE: GSK) reported preliminary results of the OSCAR (Otilimab in Severe COVID-19 Related Disease) study using otilimab (formerly...

Read more

Citizen Stash Expands Its Product Line by 44% in Ontario, Canada’s Largest Cannabis Market

March 2, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / March 2, 2021 / Experion Holdings Ltd. (the "Company" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular Citizen Stash brand, is pleased to announce a 44% increase of its premium product line up with the Ontario Cannabis Store (OCS) bringing its total registered product SKUs in the province to...

Read more

Nascent Biotech Earns US Patent for Crossing Blood-Brain Barrier

March 2, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / March 2, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a clinical-stage biotechnology Company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is excited to announce that the Company has officially received allowance for a "Method-of-Use" patent by the US Patent and Trademark Office ("USPTO") for their...

Read more

Apollo Endosurgery Receives FDA Breakthrough Device Designation for the Orbera(R) Intragastric Balloon for Treatment of Patients with NASH

March 1, 2021 6:30 AM

AUSTIN, TX / ACCESSWIRE / March 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that it has received a Breakthrough Device Designation from the U.S. Food and Drug Administration for the Orbera® Intragastric Balloon, specifically for the indication for use in treating patients with BMI between 30-40 kg/m2 with...

Read more

Molecular Partners Publishes Audited Financial Results for 2020 and Annual Report 2020

February 26, 2021 1:00 AM

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / February 26, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics, today published its audited Financial Results for 2020 and the company's 2020 Annual Report. The Audited Financial Results for 2020 and the company's 2020 Annual Report are available on the investors section of the company's...

Read more

Edesa Biotech Increases Previously Announced Bought Deal Offering of Common Shares to $10.0 Million

February 25, 2021 10:20 PM

TORONTO, ON / ACCESSWIRE / February 25, 2021 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 1,562,500 common shares of Edesa, at a price to the public of $6.40 per share, less underwriting...

Read more

Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares

February 25, 2021 5:12 PM

TORONTO, ON / ACCESSWIRE / February 25, 2021 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 546,875 common shares of Edesa, at a price to the public of $6.40 per share, less underwriting...

Read more

Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2020 Results

February 25, 2021 4:01 PM

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / February 25, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the fourth quarter and year ended December 31, 2020. The Company will hold a conference call today at 3:30 p.m. CT / 4:30 p.m. ET to discuss...

Read more

Tetra Bio-Pharma To Monetize Its Dronabinol And Botanical Product Portfolios

February 25, 2021 7:00 AM

Company signs LOI for Nordics and Germany OTTAWA, ON / ACCESSWIRE / February 25, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a biopharmaceutical pioneer in immunomodulator drug discovery and development announced the signing of a Letter of Intent with DanCann Pharma A/S (SS: DANCAN) for the exclusive distribution of Reduvo™ Adversa® and QIXLEEF™ in Denmark, Norway, Sweden, Finland, and...

Read more

American CryoStem and BioTherapeutic Labs Corp. Enter into R&D, Collaboration and Marketing Agreement

February 25, 2021 1:00 AM

EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida. CRYO will optimize cell recovery from...

Read more

First U.S. Patent Allowed on Hancock Jaffe VenoValve

February 24, 2021 12:05 PM

Company Receives Notice of Allowance from U.S. Patent and Trademark Office IRVINE, CA / ACCESSWIRE / February 24, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a patent covering the company's VenoValve. The patent, which focuses on novel...

Read more

Citizen Stash Cannabis Edibles Enters Largest Canadian Market

February 24, 2021 8:45 AM

VANCOUVER, BC / ACCESSWIRE / February 24, 2021 / Experion Holdings Ltd. (the "Corporation" or "Experion") (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis supply and builder of premium cannabis brands including its sought after and popular brand Citizen Stash, announced today the launch of it's edible 5mg gummy into the Ontario Market. Designed for the legal adult recreational market, Citizen Stash's gummy product...

Read more

MJ Biotech Offers Covid-19 FDA Approved Nasopharyngeal Specimen Collection Swabs RT-PCR COVID Test Kit

February 24, 2021 7:02 AM

CHEYENNE, WY / ACCESSWIRE / February 24, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report that Sterile and individually wrapped FDA approved nasopharyngeal (nasal) specimen collection swabs for the RT-PCR COVID test was added to the COVID -19 product line. This Covid-19 test (inclusive of the swabs to the RT-PCR test) is in addition to the Covid-19 IgG/IgM Antibody Rapid Test Kits already being offered by MJ Biotech, Inc. Sales...

Read more